林菁菁, 杨亚军, 沈珑瑛, 潘显道. 抗肿瘤药玫瑰树碱及其衍生物的合成和药理研究进展J. 药学学报, 2017,52(9): 1387-1396. doi: 10.16438/j.0513-4870.2017-0230
引用本文: 林菁菁, 杨亚军, 沈珑瑛, 潘显道. 抗肿瘤药玫瑰树碱及其衍生物的合成和药理研究进展J. 药学学报, 2017,52(9): 1387-1396. doi: 10.16438/j.0513-4870.2017-0230
LIN Jing-jing, YANG Ya-jun, SHEN Long-ying, PAN Xian-dao. Recent progress in synthesis and pharmacological effects of ellipticine and its derivativesJ. Acta Pharmaceutica Sinica, 2017,52(9): 1387-1396. doi: 10.16438/j.0513-4870.2017-0230
Citation: LIN Jing-jing, YANG Ya-jun, SHEN Long-ying, PAN Xian-dao. Recent progress in synthesis and pharmacological effects of ellipticine and its derivativesJ. Acta Pharmaceutica Sinica, 2017,52(9): 1387-1396. doi: 10.16438/j.0513-4870.2017-0230

抗肿瘤药玫瑰树碱及其衍生物的合成和药理研究进展

Recent progress in synthesis and pharmacological effects of ellipticine and its derivatives

  • 摘要: 玫瑰树碱(ellipticine)是一种来源于天然产物的细胞毒生物碱,具有抗肿瘤作用和抗艾滋病毒活性。自1959年首次被分离后,众多合成化学家设计并完成了玫瑰树碱的全合成路线。本文根据起始原料的不同对玫瑰树碱及衍生物的合成方法进行了综述,同时探讨了该类化合物的抗肿瘤活性作用机制,还对玫瑰树碱的抗肿瘤的构效关系进行了总结。

     

    Abstract: Ellipticine is an alkaloid isolated from natural product with cytotoxicity, which has antitumor and anti-aids activity. Since it was first identified in 1959, a great deal of effort has been devoted to the development of various approaches for synthesis of ellipticine. This review provides a summary for synthesis approaches of ellipticine from different starting materials. The antitumor mechanism and structure-activity relationship are also discussed.

     

/

返回文章
返回